CD19 and common variable immunodeficiency: It is also worth pointing out that, in our patients with pediatric CVID, same as in children with autoimmune cytopenias reported in (36), either GLILD or any other granulomatous lymphoproliferative manifestations were not associated with increased numbers of immature B-cell subset with CD19+CD21lo immunophenotype, in which expansion has been hypothesized to be a predictor of granulomatous complications in CVID (8, 44, 45).